ArticlePublished 2006
Prophylactic Administration of Somatostatin (SS) or Gabexate (GM) Does not Prevent Pancreatic Damage after ERCP. An Updated Meta-Analysis
Subjects
Gastroenterology & HepatologyFollow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalJournal of the Pancreas Open Access
- SubjectGastroenterology & Hepatology
- BylineArticles whose byline prints “Andriulli A”
- BylineArticles whose byline prints “Leandro G”
- BylineArticles whose byline prints “Caruso N”
- BylineArticles whose byline prints “Ippolito A”
- BylineArticles whose byline prints “Forlano R”
- BylineArticles whose byline prints “Iacobellis A”
- BylineArticles whose byline prints “Annese V”
